Genomic Epidemiology of 2023-2024 Oropouche Outbreak in Iquitos, Peru reveals independent origin from a concurrent outbreak in Brazil

medRxiv [Preprint]. 2024 Dec 10:2024.12.08.24318674. doi: 10.1101/2024.12.08.24318674.

Abstract

Oropouche virus is an arbovirus endemic to the Americas. Periodic outbreaks have occurred since its description in 1955. In late 2023, an outbreak occurred in Peru, centered in and around Iquitos in the Eastern Peruvian Amazon. An existing acute febrile illness (AFI) surveillance program was able to document its emergence and characterize arthralgia and dysuria and the absence of diarrhea as distinctive clinical features of Oropouche virus-associated febrile illness relative to other causes of AFI. Sequencing of isolates from the outbreak demonstrated that strains from this region were distinct from those causing disease in Brazil, despite the large-scale movement of people along the Amazon corridor, but highly similar to strains from Colombia and Ecuador. Our findings suggest that the current outbreak in South America is fundamentally multifocal in origin and not the result of geographic spread from Brazil, which experienced an outbreak between 2022 and 2024.

Keywords: acute febrile illness; arbovirus; orthobunyavirus.

Publication types

  • Preprint

Grants and funding

This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a cooperative agreement award with CDC/HHS, award number U01GH002270 to MNK. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention. Additional training and capacity-building support was obtained through the National Institutes of Health/Fogarty International Center (D43TW010913 to MNK; K43TW012298 to FS), the National Institutes of Health/National Institute for Allergies and Infectious Diseases (K01AI168493 to JMC), the Infectious Diseases Training Program 5T32AI007046-48 and the Division of Infectious Diseases and International Health of the University of Virginia.